How to Identify Cardiac Amyloidosis Patients Who Might Benefit From Cardiac Transplantation
JACC Heart Fail
.
2023 Jan;11(1):115-120.
doi: 10.1016/j.jchf.2022.10.012.
Authors
Amrut V Ambardekar
1
,
Marianna Fontana
2
,
Mathew S Maurer
3
,
Barry Trachtenberg
4
,
Michelle Kittleson
5
Affiliations
1
Division of Cardiology, University of Colorado, Aurora, Colorado, USA. Electronic address: Amrut.Ambardekar@ucdenver.edu.
2
National Amyloidosis Centre, University College London, London, England. Electronic address: https://twitter.com/dr_m_fontana.
3
Columbia University Irving Medical Center, New York, New York, USA. Electronic address: https://twitter.com/MathewMaurer.
4
J.C. Walter Houston Methodist Transplant Center, Houston Methodist, Houston, Texas, USA. Electronic address: https://twitter.com/bhtrachtenberg.
5
Department of Cardiology, Smidt Heart Institute, Cedars Sinai, Los Angeles, California, USA. Electronic address: https://twitter.com/MKittlesonMD.
PMID:
36599538
DOI:
10.1016/j.jchf.2022.10.012
No abstract available
Keywords:
amyloidosis; heart failure; heart transplant.
Publication types
Editorial
MeSH terms
Amyloidosis* / diagnosis
Amyloidosis* / surgery
Cardiomyopathies* / surgery
Heart Failure* / surgery
Heart Transplantation*
Humans